Origo Acquisition Priced, Nasdaq: OACQ
Biotech-focused blank check company backed by Coronado Biosciences (liquidated).
Industry: SPAC
First Day Return: 0.0%
Industry: SPAC
OACQ
Biotech-focused blank check company backed by Coronado Biosciences (liquidated).
| IPO Data | |
|---|---|
| IPO File Date | 10/23/2014 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 4.0 |
| Deal Size ($mm) | $40 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 12/12/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $40 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Burlington, MA, United States |
| Founded | 2014 |
| Employees at IPO | 0 |
| Website www.coronadobiosciences.com | |
IPO News for Origo Acquisition
Origo Acquisition (OACQ) Performance
